Biovectra Mrna Vaccine And Biomanufacturing Centre, Charlottetown, Canada

  Address - United States

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 10687879

  Document Type - Tender Notices

Description - Scope : Scheduled for completion in 2023, Biovectra’s new facility will provide space to support mRNA and pDNA expansions.Construction of the new current good manufacturing practice (cGMP)-compliant facility took place in April 2022 and is expected to be completed in 2023.The facility is pivotal to the company’s expansion plans to create an end-to-end solution for producing vaccines and therapies.It is also expected to support the Government of Canada’s strategy to strengthen the domestic life sciences sector with advanced biomanufacturing capabilities. The move will increase the country’s preparedness for future pandemics and other health emergencies.The company expects to generate

Mt Ref Id - 10687879

Deadline - Dec 31, 2023